» Articles » PMID: 30950227

Resveratrol Attenuates the Pathogenic and Inflammatory Properties of Porphyromonas Gingivalis

Overview
Specialties Dentistry
Microbiology
Date 2019 Apr 6
PMID 30950227
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Porphyromonas gingivalis has been strongly associated with chronic periodontitis, which affects tooth-supporting tissues. This Gram-negative anaerobic bacterium produces a repertoire of virulence factors that modulate tissue destruction directly or indirectly by the induction of inflammatory processes. The aim of this study was to investigate the effects of resveratrol, a major polyphenol found in grapes and wine, on the growth and virulence properties of P. gingivalis as well as on gingival keratinocyte tight junction integrity and the host inflammatory response. Resveratrol exhibited antibacterial activity that may result from damage to the bacterial cell membrane. Resveratrol also killed a pre-formed P. gingivalis biofilm and reduced bacterial adherence to matrix proteins. In addition, resveratrol had a protective effect on the integrity of the keratinocyte tight junctions by inhibiting its breakdown by P. gingivalis. This may be related to the ability of resveratrol to inhibit the protease activities of P. gingivalis. Lastly, resveratrol reduced P. gingivalis-mediated activation of the NF-κB signaling pathway and attenuated TREM-1 gene expression as well as soluble TREM-1 secretion in monocytes. The effect on NF-κB activation likely results from the ability of resveratrol to act as a PPAR-γ agonist. In summary, the antibacterial, anti-adherence, and antiprotease properties of resveratrol, as well as its ability to protect the gingival keratinocyte barrier and attenuate the inflammatory response in monocytes suggest that it may be a promising novel therapeutic agent for treating periodontal disease.

Citing Articles

Optimization of Cellulose Derivative-, PVA-, and PVP-Based Films with Extract to Improve Periodontal Disease Treatment.

Dolowacka-Jozwiak A, Nawrot-Hadzik I, Matkowski A, Nowakowski P, Dudek-Wicher R, Markowska D Materials (Basel). 2025; 17(24.

PMID: 39769807 PMC: 11677500. DOI: 10.3390/ma17246205.


Combination of Cannabidiol with Taurine Synergistically Treated Periodontitis in Rats.

Kim S, Shrestha S, Chuluunbaatar B, Soh Y Biomol Ther (Seoul). 2024; 33(1):203-209.

PMID: 39632669 PMC: 11704405. DOI: 10.4062/biomolther.2024.104.


NF-κB Signaling Pathway in Rheumatoid Arthritis: Mechanisms and Therapeutic Potential.

Liao H, Zheng J, Lu J, Shen H Mol Neurobiol. 2024; .

PMID: 39560902 DOI: 10.1007/s12035-024-04634-2.


Effect of oxyresveratrol under in vitro lipopolysaccharide-induced periodontitis environment.

Ye J, Park S, Kang S, Kwack K, Chae Y, Lee H BMC Oral Health. 2024; 24(1):1382.

PMID: 39548434 PMC: 11566898. DOI: 10.1186/s12903-024-05128-2.


Promising potential effects of resveratrol on oral and dental health maintenance: a comprehensive review.

Farhad S, Karbalaeihasanesfahani A, Dadgar E, Nasiri K, Hosseini N, Valian N Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1367-1389.

PMID: 39305330 DOI: 10.1007/s00210-024-03457-1.